78 results
10-Q
2014 Q3
NMRD
Nemaura Medical Inc
11 Sep 14
Quarterly report
12:00am
Of Comprehensive Income/(Loss)
(Unaudited)
Three Months Ended
June 30,
Revenue:
Total revenue
Operating Expenses:
Research and development
General … the agreement.
Research and Development Expenses
The Company charges research and development expenses to operations as incurred. Research
424B3
blgqk39vf212ggxicgsw
17 Nov 14
Prospectus supplement
12:00am
8-K
EX-99.1
8hmqo i23d76s1ajnaj
30 Jun 21
Results of Operations and Financial Condition
8:00am
10-K
syv s7gayn7e
23 Jun 15
Annual report
12:00am